More languages
More actions
(Use less assertive wording and generalize criticisms.) |
General-KJ (talk | contribs) m (Fixed a reference) Tag: Visual edit |
||
| Line 20: | Line 20: | ||
=== Psychiatric Drugs=== | === Psychiatric Drugs=== | ||
Critics of Psychiatric drugs argue that the efficacy of psychiatric drugs are equivalent to a placebo; and that psychiatric drugs are more harmful due to side effects. This criticism aligns with some studies that argue psychiatric drugs lack long-term studies and a control group.<ref name=mdd-treatments- | Critics of Psychiatric drugs argue that the efficacy of psychiatric drugs are equivalent to a placebo; and that psychiatric drugs are more harmful due to side effects. This criticism aligns with some studies that argue psychiatric drugs lack long-term studies and a control group.<ref name="mdd-treatments-uneffective2">{{Citation|author=Arif Khan, James Faucett, Pesach Lichtenberg, Irving Kirsch, Walter A. Brown|year=2012|title=A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression|doi=10.1371/journal.pone.0041778}}</ref><ref>{{Citation|title=Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive | ||
disorder: a systematic review and network meta-analysis|doi=10.1016/S0140-6736(17)32802-7|author=Andrea Cipriani, Toshi A Furukawa|year=2018|publisher=Lancet}}</ref><ref>{{Citation|title=Antidepressants versus placebo in major depression: an overview|doi=10.1002/wps.20241|author=Arif Khan, Walter A. Brown|publisher=World Psychiatry|year=2015}}</ref> | disorder: a systematic review and network meta-analysis|doi=10.1016/S0140-6736(17)32802-7|author=Andrea Cipriani, Toshi A Furukawa|year=2018|publisher=Lancet}}</ref><ref>{{Citation|title=Antidepressants versus placebo in major depression: an overview|doi=10.1002/wps.20241|author=Arif Khan, Walter A. Brown|publisher=World Psychiatry|year=2015}}</ref> | ||
| Line 31: | Line 31: | ||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Psychiatry]] | |||
Latest revision as of 16:19, 21 October 2024
Critics of Psychiatry have many criticisms of the field of Psychiatry.
Scientific Review[edit | edit source]
Validity of Psychiatry as a Science[edit | edit source]
Some critics argue that, while the majority of Psychiatry research lacks much scientific evidence, Psychiatry is still a science.
Anti-psychiatry advocates argue that Psychiatry is a pseudoscience; as the fundamental basis for Psychiatry (mental disorders) lack biological testing.
Psychiatric Diagnoses[edit | edit source]
Critics of Psychiatric diagnoses argue that Psychiatric diagnoses:
- Do not use and require any objective analysis.
- Lack scientific research to justify the criteria for the disorders
- Do not hold discernible consistent criteria.
- Most psychiatric disorders are diagnosed through subjective analysis by a psychiatrist.
Psychiatric Drugs[edit | edit source]
Critics of Psychiatric drugs argue that the efficacy of psychiatric drugs are equivalent to a placebo; and that psychiatric drugs are more harmful due to side effects. This criticism aligns with some studies that argue psychiatric drugs lack long-term studies and a control group.[1][2][3]
Chemical Imbalance Theory[edit | edit source]
The chemical imbalance theory is a theory which suggested that a lack of serotonin causes Major Depression Disorder. It was generated by pharmaceutical marketing campaigns for antidepressants around the 1970s. The chemical imbalance theory has since been disproved.[4] Major Depression Disorder has also been found to have scare objective biomarkers and biological models.[5]
In response to Psychiatry critics, Psychiatrists Andrew McIntosh[6], Christopher Davey[7], and Genetic Epidemiologist Cathryn Lewis[6] have responded to the study by claiming that antidepressants still work regardless if the chemical imbalance theory is wrong.
References[edit | edit source]
- ↑ Arif Khan, James Faucett, Pesach Lichtenberg, Irving Kirsch, Walter A. Brown (2012). A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression. doi: 10.1371/journal.pone.0041778 [HUB]
- ↑ Andrea Cipriani, Toshi A Furukawa (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. doi: 10.1016/S0140-6736(17)32802-7 [HUB]
- ↑ Arif Khan, Walter A. Brown (2015). Antidepressants versus placebo in major depression: an overview. World Psychiatry. doi: 10.1002/wps.20241 [HUB]
- ↑ Joanna Moncrieff, Ruth E. Cooper, Tom Stockmann (2022). The serotonin theory of depression: a systematic umbrella review of the evidence.. [PDF] Molecular Psychiatry. doi: 10.1038/s41380-022-01661-0 [HUB]
- ↑ Mark Horowitz, Joanna Moncrieff. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Molecular Psychiatry. doi: 10.1038/s41380-019-0585-z [HUB]
- ↑ 6.0 6.1 Andrew M McIntosh, Cathryn Lewis (2022-07-22). "Depression: low serotonin may not be the cause – but antidepressants still work" The Conversation.
- ↑ Christopher Davey (2022-08-02). "The chemical imbalance theory of depression is dead, but that doesn’t mean antidepressants don’t work" The Conversation.